Physiotherapy Intervention Program for Chronic Pain Associated With Depressive Disorder

NCT07764848 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-08-14

No results posted yet for this study

Summary

This prospective longitudinal pre-post intervention study aims to evaluate the effects of an 8-week physiotherapy program combining face-to-face and asynchronous tele-rehabilitation sessions in individuals with chronic persistent pain and depressive disorder. The intervention is based on pain neuroscience education and therapeutic exercise. Outcomes include pain intensity, psychosocial factors, adherence to treatment, usability of telemedicine, balance, body awareness, and participants' experiences collected through focus groups.

Conditions

Interventions

OTHER

Hybrid Physiotherapy Program

Hybrid Physiotherapy Program consisted of Pain Neuroscience Education and Therapeutic Exercise: Behavioral: Pain Neuroscience Education Eight weekly face-to-face educational sessions complemented by asynchronous telematic educational videos covering pain neurophysiology, biopsychosocial approaches, neuroplasticity, motor imagery and self-management strategies. Behavioral: Therapeutic Exercise Eight weeks of supervised group exercise. Exercises include strength, aerobic, balance, flexibility, coordination and dual-task activities.

Sponsors & Collaborators

  • Universidad San Jorge

    collaborator OTHER
  • Instituto de Investigación Sanitaria Aragón

    lead OTHER

Principal Investigators

  • Sandra S Calvo, Phd · University Zaragoza

  • Carolina C Jiménez-Sánchez, Phd · San Jorge University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2026-05-30
Completion
2026-05-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07764848 on ClinicalTrials.gov